Suppr超能文献

鉴定患有中性粒细胞减少性非典型性皮肤异色症的阿萨巴斯卡患者中的新型 C16orf57 突变。

Identification of a novel C16orf57 mutation in Athabaskan patients with Poikiloderma with Neutropenia.

机构信息

Department of Pediatrics, University of New Mexico School of Medicine, Albuquerque, New Mexico, USA.

出版信息

Am J Med Genet A. 2011 Feb;155A(2):337-42. doi: 10.1002/ajmg.a.33807. Epub 2010 Dec 22.

Abstract

Poikiloderma with Neutropenia (PN), Clericuzio-Type (OMIM #604173) is characterized by poikiloderma, chronic neutropenia, recurrent sinopulmonary infections, bronchiectasis, and nail dystrophy. First described by Clericuzio in 1991 in 14 patients of Navajo descent, it has since also been described in non-Navajo patients. C16orf57 has recently been identified as a causative gene in PN. The purpose of our study was to describe a spectrum of C16orf57 mutations in a cohort of PN patients including five patients of Athabaskan (Navajo and Apache) ancestry. Eleven patients from eight kindreds were enrolled in an IRB-approved study at Baylor College of Medicine. Five patients were of Athabaskan ancestry. PCR amplification and sequencing of the entire coding region of the C16orf57 gene was performed on genomic DNA. We identified biallelic C16orf57 mutations in all 11 PN patients in our cohort. The seven new deleterious mutations consisted of deletion (2), nonsense (3), and splice site (2) mutations. The patients of Athabaskan ancestry all had a common deletion mutation (c.496delA) which was not found in the six non-Athabaskan patients. Mutations in the C16orf57 gene have been identified thus far in all patients studied with a clinical diagnosis of PN. We have identified seven new mutations in C16orf57 in PN patients. One of these is present in all patients of Athabaskan descent, suggesting that c.496delA represents the PN-causative mutation in this subpopulation.

摘要

斑丘状中性粒细胞减少症(PN),Clericuzio 型(OMIM #604173)的特征是斑丘状皮肤改变、慢性中性粒细胞减少症、反复的肺和鼻窦感染、支气管扩张和指甲营养不良。该疾病由 Clericuzio 于 1991 年首次在 14 名具有纳瓦霍人血统的患者中描述,此后也在非纳瓦霍人患者中被描述过。最近已鉴定出 C16orf57 是 PN 的致病基因。我们的研究目的是描述一组包括 5 名 Athabaskan(纳瓦霍人和阿帕切人)血统的 PN 患者的 C16orf57 基因突变谱。在贝勒医学院进行的一项 IRB 批准的研究中,招募了来自 8 个家族的 11 名患者。其中 5 名患者具有 Athabaskan 血统。对基因组 DNA 进行 C16orf57 基因全长编码区的 PCR 扩增和测序。我们在我们的队列中的 11 名 PN 患者中均发现了 C16orf57 基因的双等位基因突变。这 7 个新的有害突变包括缺失(2)、无义(3)和剪接位点(2)突变。Athabaskan 血统的患者均具有共同的缺失突变(c.496delA),而在 6 名非 Athabaskan 患者中未发现该突变。迄今为止,在所有具有 PN 临床诊断的患者中均已鉴定出 C16orf57 基因突变。我们在 PN 患者的 C16orf57 中发现了 7 个新突变。其中一个存在于所有 Athabaskan 血统的患者中,表明 c.496delA 代表该亚群的 PN 致病突变。

相似文献

1
Identification of a novel C16orf57 mutation in Athabaskan patients with Poikiloderma with Neutropenia.
Am J Med Genet A. 2011 Feb;155A(2):337-42. doi: 10.1002/ajmg.a.33807. Epub 2010 Dec 22.
3
Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria.
Br J Dermatol. 2010 Oct;163(4):866-9. doi: 10.1111/j.1365-2133.2010.09929.x. Epub 2010 Sep 7.
5
Poikiloderma with neutropenia: report of three cases including one with calcinosis cutis.
Pediatr Dermatol. 2012 Jul-Aug;29(4):463-72. doi: 10.1111/j.1525-1470.2011.01513.x. Epub 2011 Oct 4.
7
Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene.
Am J Hum Genet. 2010 Jan;86(1):72-6. doi: 10.1016/j.ajhg.2009.11.014. Epub 2009 Dec 10.
10
Systematic search for neutropenia should be part of the first screening in patients with poikiloderma.
Eur J Med Genet. 2012 Jan;55(1):8-11. doi: 10.1016/j.ejmg.2011.07.004. Epub 2011 Aug 18.

引用本文的文献

1
Poikiloderma With Neutropenia and Mastocytosis: A Case Report and a Review of Dermatological Signs.
Front Med (Lausanne). 2021 Jun 10;8:680363. doi: 10.3389/fmed.2021.680363. eCollection 2021.
2
Weaving the Strands of Life (): History of Genetic Research Involving Navajo People.
Hum Biol. 2020 Jul 9;91(3):189-208. doi: 10.13110/humanbiology.91.3.04.
4
Neutrophil Evolution and Their Diseases in Humans.
Front Immunol. 2017 Aug 28;8:1009. doi: 10.3389/fimmu.2017.01009. eCollection 2017.
5
Marked overlap of four genetic syndromes with dyskeratosis congenita confounds clinical diagnosis.
Haematologica. 2016 Oct;101(10):1180-1189. doi: 10.3324/haematol.2016.147769. Epub 2016 Sep 9.
6
The pathogenicity of splicing defects: mechanistic insights into pre-mRNA processing inform novel therapeutic approaches.
EMBO Rep. 2015 Dec;16(12):1640-55. doi: 10.15252/embr.201541116. Epub 2015 Nov 13.
9
Clinical utility gene card for: poikiloderma with neutropenia.
Eur J Hum Genet. 2013 Oct;21(10). doi: 10.1038/ejhg.2012.298. Epub 2013 Jan 16.

本文引用的文献

2
Poikiloderma with neutropenia: a novel C16orf57 mutation and clinical diagnostic criteria.
Br J Dermatol. 2010 Oct;163(4):866-9. doi: 10.1111/j.1365-2133.2010.09929.x. Epub 2010 Sep 7.
4
Targeted next-generation sequencing appoints c16orf57 as clericuzio-type poikiloderma with neutropenia gene.
Am J Hum Genet. 2010 Jan;86(1):72-6. doi: 10.1016/j.ajhg.2009.11.014. Epub 2009 Dec 10.
6
Poikiloderma with neutropenia, Clericuzio type, in a family from Morocco.
Am J Med Genet A. 2008 Nov 1;146A(21):2762-9. doi: 10.1002/ajmg.a.32524.
7
Clericuzio type poikiloderma with neutropenia is distinct from Rothmund-Thomson syndrome.
Am J Med Genet A. 2005 Jan 15;132A(2):152-8. doi: 10.1002/ajmg.a.30430.
8
Association between osteosarcoma and deleterious mutations in the RECQL4 gene in Rothmund-Thomson syndrome.
J Natl Cancer Inst. 2003 May 7;95(9):669-74. doi: 10.1093/jnci/95.9.669.
9
Absence of RECQL4 mutations in poikiloderma with neutropenia in Navajo and non-Navajo patients.
Am J Med Genet A. 2003 Apr 30;118A(3):299-301. doi: 10.1002/ajmg.a.10057.
10
Rothmund-Thomson syndrome (Thomson-type) and myelodysplasia.
Pediatr Dermatol. 2001 Sep-Oct;18(5):422-5. doi: 10.1046/j.1525-1470.2001.01971.x.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验